FindTrial
Sign In

a study of HER-2 over expression on circulating tumor cell (CTC) on breast cancer patients

a study of HER-2 over expression on circulating tumor cell (CTC) on breast cancer patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015712
Enrollment
Unknown
Registered
2018-04-16
Start date
2017-11-15
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:Pathological results
Index test:CTC-HER2

Sponsors

Zhuhai Maternityand Child Care
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The patients agree to participate in the trials and sign the informed consent and date; 2. Aged 18-70 years; 3. Be able to follow the scheme; 4. No other malignancy; 5. Patients were diagnosed with breast cancer.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating female patients; 2. Still in other study at the same time; 3. Patients with clear surgical contraindications; 4. The researchers believe that the patients are not suitable for this clinical trial for other reasons.

Design outcomes

Primary

MeasureTime frame
;—

Countries

China

Contacts

Public ContactWEIRONG CHEN

Zhuhai Maternityand Child Care

924743255@qq.com+86 13217569800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026